Products
RIV-5061 | Revivo Therapeutics
Product description
RIV-5061 is a novel small molecule drug candidate under development by Revivo Therapeutics for the treatment of Mild Cognitive Impairment (MCI) and other forms of cognitive decline. It targets [specific mechanism - details to be added upon further research].